Status:
COMPLETED
Move Study in Healthy Aging People
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Joint Pain
Eligibility:
All Genders
45-65 years
Phase:
NA
Brief Summary
Bone and muscle losses occur during ageing leading to increased risk of osteoporosis (there are more than 200 million people affected by osteoporosis worldwide), sarcopenia, loss of functionality and ...
Eligibility Criteria
Inclusion
- Target 45-65 y old
- Suffering from (knee) pain. VAS on pain assessment \<= 4 on a range 0 to 10
- 20\<BMI\<28
- Time since menopause above 2y
- iPAQ (International Physical Activity Questionnaire) score \<600
Exclusion
- OA diagnosed
- Medicine treatment
- Chronic pain killers treatment for more than 7 consecutive days with a washout period of 2 weeks between 2 periods of treatment
- Under corticoid, hormone (adrenal, thyroid) treatment
- Traditional herbal medicine: in particular with claims on strengthening tendons and bones. This point will be included in FFQ (see annex) and evaluate.
- Subjects with chronic tablets supplementation ( calcium or drinking milk over 5 day wk-1 will be excluded, vitamin D, GS, or any with effect on bone and joints ) (set up a FFQ to specially investigate intakes of calcium tablets, milk and animal foods)
- Pregnancy
- Subject with knee/joint surgery/replacement and CLA (Cross Ligament) injury
- History of relevant digestive disease, organic disease of heart, liver or kidney, severe function disorder of liver or kidney, metabolic/endocrine , neurological disease (e.g., Parkinson disease, stroke) with residual impairment, vertigo
- Anaemia
- Unable to carry out functional tests and questionnaires correctly (KOOS, physical activity)
- Lower or upper extremity surgery or fracture in the last 3 months
- Currently participating or having participated in another clinical trial in the three previous months
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2016
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT02276183
Start Date
April 1 2015
End Date
August 1 2016
Last Update
November 28 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China